Evoke Pharma - Stock Split History | EVOK

Stock split history for Evoke Pharma since 2019. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Evoke Pharma Annual Stock Splits
Evoke Pharma Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.025B $0.000B
Evoke Pharma, Inc. is a specialty pharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. The Company's lead product candidate, EVK-001, is in late stage clinical testing which is intended for the treatment of diabetic gastroparesis. Evoke Pharma, Inc. is based in San Diego, California.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $59.901B 10.92
Teva Pharmaceutical Industries (TEVA) Israel $10.233B 4.16
Bausch Health Cos (BHC) Canada $9.765B 6.45
Mylan (MYL) United States $8.908B 4.00
Dr Reddy's Laboratories (RDY) India $6.344B 16.64
ASPEN PHARMACR (APNHY) South Africa $3.666B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.145B 11.08
Amphastar Pharmaceuticals (AMPH) United States $0.801B 41.63
Homology Medicines (FIXX) United States $0.587B 0.00
Akorn (AKRX) United States $0.517B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.506B 0.00
Voyager Therapeutics (VYGR) United States $0.485B 0.00
CymaBay Therapeutics (CBAY) United States $0.370B 0.00
Assembly Biosciences (ASMB) United States $0.314B 0.00
Mallinckrodt Public Limited Company (MNK) United Kingdom $0.235B 0.32
Adamas Pharmaceuticals (ADMS) United States $0.156B 0.00
Sol-Gel Technologies (SLGL) Israel $0.144B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.142B 0.00
Teligent (TLGT) United States $0.034B 0.00
China Pharma Holdings (CPHI) China $0.011B 0.00